Not only is nonalcoholic steatohepatitis (NASH) and its precursor, nonalcoholic fatty liver disease (NAFLD), virtually unheard of among the most high-risk patient population, it’s difficult to diagnose and it disproportionately affects those who are already marginalized. This poses a dramatic problem for clinical trial enrollment, since the next five years will see more than 60 sponsors attempt to randomize nearly 30,000 NASH patients into clinical trials.

The prevalence of NASH is estimated to be up to 25 percent of the population in the developed world, yet fewer than two percent of people have even heard of it. This will become a monumental challenge for clinical trial enrollment. Moreover, awareness barely increases (up to six percent) among those most at risk for developing the chronic, potentially fatal condition. Finding patients to randomize in to a clinical trial will require a multi-pronged approach: deep understanding of the patient journey, a full commitment to patient and community engagement, targeted, empathetic recruitment campaign messaging and smart, data-driven site support.

In this webinar, participants will learn:

Results of a proprietary insights study conducted with this at-risk patient population
How low awareness among patients and healthcare professionals impacts clinical trial enrollment
Patient journey insights to inform education and engagement strategies
Campaign messaging strategies designed to maximize referrals
Analytic-driven, site-level recruitment solutions

Keywords:

Speakers

Pamela Landau, Senior Vice President Patient Recruitment, Continuum Clinical

Pamela Landau has more than 20 years of experience in global marketing strategy and leadership experience, with 10+ years specific to healthcare, technology and communications. As Senior Vice President of Patient Recruitment, Pamela combines her experience in direct marketing with insights-driven, patient-centric strategy to help connect patients to promising new therapies, as well as to help accelerate clinical trials and drug development. She applies her passion for patient engagement and thorough understanding of the patient’s lived experience and unmet needs to every recruitment program.

Message Presenter

Bob Klein, Chief Insights and Experience Officer, Continuum Clinical

As Chief Insights and Experience Officer, Bob Klein focuses on insights-driven strategic planning to help clients accelerate enrollment and maximize retention in clinical trials. He joined the team in 2006, after leading communication planning for world-class brands at several global marketing communications agencies. Under his leadership, the Insights and Experience team leverages a variety of proprietary testing methodologies, including concept testing benchmarked against the industry’s only normative database to ensure communications are relevant and impactful. In 2013, Bob was named to the PharmaVOICE 100.

Message Presenter

Wayne Eskridge, CEO, Fatty Liver Foundation

Wayne Eskridge, an electrical engineer from the University of Idaho, worked in software and electronics through a 50-year professional career. From his early role as a computer programmer, he moved on to serve in many technical and managerial roles at multiple levels in businesses of all sizes. He held executive positions in both public and private corporations with worldwide responsibilities, and from start-ups to Fortune 500 firms.

Mr. Eskridge was first diagnosed with liver disease in 2010 and, through his own experiences, he became aware of an acute need for an educational resource from a patient perspective. At the core of his motivation is the fact that an estimated 100 million Americans already have fatty liver disease and are unaware of it. As there is currently no medical treatment for NAFLD/NASH, through his work as a patient advocate and founder of the Fatty Liver Foundation, he focuses on prevention and education to support others in avoiding his experiences.

Message Presenter

Qin Ye, MD, MS, Associate Principal, ZS Associates

As head of Global Real World Evidence at ZS, Qin Ye leads the development of their RWE team, oversees the product development of their RWE technology and delivery of advanced real world analytics services. He works directly with clients on RWE programs across clinical, health economics and outcomes research, medical and commercial functions. As a trained physician and data scientist, Qin has over 20 years of health informatics and data analytics experiences with in-depth knowledge of medical terminologies, data standards, clinical registries and various electronic health records products, pragmatics trials designs, observational study methods and health economics.

Message Presenter

Who Should Attend?

This webinar will appeal to senior professionals like Chief Medical Officers and Chief Scientific Officers, as well as directors and VPs of:

Clinical Affairs
Clinical Development
Clinical Operations
Clinical Studies
Clinical Trials
Data Analytics

What You Will Learn

In this webinar, participants will learn:

Results of a proprietary insights study conducted with this at-risk patient population
How low awareness among patients and healthcare professionals impacts clinical trial enrollment
Patient journey insights to inform education and engagement strategies
Campaign messaging strategies designed to maximize referrals
Analytic-driven, site-level recruitment solutions

Xtalks Partner

Continuum Clinical

Continuum Clinical is a global clinical trial enrollment company. With over twenty-five years of experience, Continuum Clinical provides sponsors and CROs with patient recruitment and retention planning, study and site support, patient recruitment campaigns, patient advocacy and diversity & inclusion services, retention solutions, and reporting and analytics. We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion.